My ePortfolio Register   
 

Abstract | Full HTML Article | PDF ecancer 8 485 / DOI: 10.3332/ecancer.2014.485

Clinical Study

Repurposing drugs in oncology (ReDO)—Cimetidine as an anti-cancer agent

Cimetidine, the first H2 receptor antagonist in widespread clinical use, has anti-cancer properties that have been elucidated in a broad range of pre-clinical and clinical studies for a number of different cancer types. These data are summarised and discussed in relation to a number of distinct mechanisms of action. Based on the evidence presented, it is proposed that cimetidine would synergise with a range of other drugs, including existing chemotherapeutics, and that further exploration of the potential of cimetidine as an anti-cancer therapeutic is warranted. Furthermore, there is compelling evidence that cimetidine administration during the peri-operative period may provide a survival benefit in some cancers. A number of possible combinations with other drugs are discussed in the supplementary material accompanying this paper.

Keywords: Drug repurposing, cimetidine, immunostimulant, ReDO project

Loading Article Metrics ... Please wait

Related articles

Case Report: Successful palliative approach with high-intensity focused ultrasound in a patient with metastatic anaplastic pancreatic carcinoma: a case report

Abstract | Full Article | PDF Published: 21 Apr 2016 / DOI: 10.3332/ecancer.2016.635

Conference Report: Highlights of Children with Cancer UK’s Workshop on Drug Delivery in Paediatric Brain Tumours

Abstract | Full Article | PDF Published: 31 Mar 2016 / DOI: 10.3332/ecancer.2016.630

Clinical Study: PET/CT with Fluorodeoxyglucose during neoadjuvant chemoradiotherapy in locally advanced rectal cancer

Abstract | Full Article | PDF Published: 29 Mar 2016 / DOI: 10.3332/ecancer.2016.629

Clinical Study: Diagnostic and therapeutic update of mantle cell lymphoma (MCL): analysis of seven cases treated in a centre in one year

Abstract | Full Article | PDF | Spanish Published: 17 Mar 2016 / DOI: 10.3332/ecancer.2016.627

Case Report: Endoscopic detection of the gastric lesions of peripheral T-cell lymphoma

Abstract | Full Article | PDF Published: 03 Mar 2016 / DOI: 10.3332/ecancer.2016.625



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence